AnaptysBio Inc (ANAB) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.75x

AnaptysBio Inc (ANAB) has a Cash Flow Reinvestment Rate of 0.75x as of December 2025, reinvesting $73.50 Million (capex $1.00K plus investments $73.50 Million) from operating cash flow of $98.00 Million. Check cash flow quality index of AnaptysBio Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.75x
(Capex + Investments) / Operating CF

Total Reinvested

$73.50 Million
Capex + Investments

Operating Cash Flow

$98.00 Million
USD

Capital Expenditures

$1.00K
USD

AnaptysBio Inc Cash Flow Reinvestment Rate (2014–2025)

Historical reinvestment intensity for AnaptysBio Inc across 2 annual periods. Explore AnaptysBio Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for AnaptysBio Inc (2014–2025)

Year-by-year capital reinvestment analysis for AnaptysBio Inc. For live market cap and broader valuation context, see AnaptysBio Inc market cap and net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 11.59x $228.21 Million $19.70 Million $87.00K ▼ -30.4%
2014 16.63x $242.91 Million $14.60 Million $145.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow